StockWatch
·

Stallion India Fluorochemicals Ltd Q1 FY27 Results

STALLIONQ1 FY27 Results
Filing
Result:GoodMargin expansionCost led
MetricValueQ4 FY26Q1 FY26
Revenue121.45 Cr10.4%9.9%
Total Income124.68 Cr12.0%12.8%
Expenditure99.89 Cr5.6%3.3%
PBT24.79 Cr48.7%78.8%
Net Profit18.58 Cr69.9%79.3%
OPM18.15%3.29pp5.21pp
NPM14.90%5.08pp5.53pp
EPS1.6020.3%22.1%
View full financials

Revenue growth was modest (9.9% YoY, trailing guided CAGR pace), but core-driven margin expansion (OPM +5.2pp YoY on lower material costs) drove adjusted PAT up ~64% even excluding one-off interest income, making this a healthy, margin-led beat rather than a top-tier standout.

Q1 FY-2027 RESULTS · STALLION

Stallion India Q1 FY27: standalone PAT jumps 79% YoY to ₹18.6 Cr as margins expand sharply

PAT +79.14% YoY · revenue +9.93% · margins expanding

12 Aug 2026 · 3 min read
Revenue

₹121.45 Cr

+9.93% YoY

PAT (standalone)

₹18.57 Cr

+79.14% YoY

Net margin

14.89%

+5.5pp YoY

EPS

₹1.6

Stallion India's standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations rose 9.9% YoY and 10.4% QoQ to ₹121.45 Cr. Net profit surged 79.1% YoY (69.8% QoQ) to ₹18.57 Cr, well ahead of topline growth. EPS was ₹1.60 (basic and diluted) against ₹1.15 a year ago and ₹1.33 last quarter.

The scoreboard

Q1 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹121.45 Cr+10.4%+9.9%
Expenses₹99.89 Cr+5.6%+3.3%
PAT₹18.57 Cr+69.79%+79.14%
Net margin14.89%+5.1pp+5.5pp
EPS₹1.6+20.3%+22.1%

The gain was margin-led. Operating margin expanded to 18.15% from 12.94% a year ago and 14.86% last quarter, while net margin rose to 15.29% from 9.37% YoY. Combined cost of materials consumed and inventory changes fell to ~76.3% of revenue from ~79.5% YoY and ~79.4% QoQ — the principal driver. Other income also rose to ₹3.23 Cr from ₹0.74 Cr YoY on interest from unutilised IPO proceeds parked in fixed deposits (note 5); stripping that out, pre-tax profit still grew ~64% YoY, so the improvement is largely operational rather than a one-off boost.

121.71162.81203.91245.01286.1125405-0906-0206-2407-1708-10
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹254, up 24% over the past month of trading.

₹ Cr
06.9313.8720.813.27Q4 FY25rev ₹152 Cr10.36Q1 FY26rev ₹110 Cr11.42Q2 FY26rev ₹106 Cr11.13Q3 FY26rev ₹105 Cr10.93Q4 FY26rev ₹110 Cr18.57Q1 FY27rev ₹121 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters.

What management guided (1 FY-2026 call)
Management projects a revenue CAGR of 30-35% over the next three years, driven by backward integration, specialty product expansion, and new facilities coming online. Margin improvements of 3-4% are also expected. The company aims for INR 3,000 crore revenue and INR 500 crore PAT by 2030, supported by continuous expans

No analyst consensus for this specific print could be confirmed via web search — a pre-results preview (Univest) flagged stabilising realisations as the key swing factor but carried no numeric revenue/PAT estimate, so street comparison is unknown. Against management's own May-2026 framework — a 30-35% three-year revenue CAGR, 3-4 points of margin improvement, and a FY27 PAT target of ₹100-110 Cr — the quarter is mixed: revenue growth of 9.9% YoY trails the guided CAGR pace, but the margin gain (OPM +5.2 points YoY) already exceeds the full multi-year magnitude guided. Annualising Q1 PAT (~₹74 Cr) trails the ₹100-110 Cr FY27 target's low end, though continued margin expansion could close the gap. No separate management press release or commentary accompanied this filing.

  • W1

    FY27 PAT guidance of ₹100-110 Cr implies ~₹25-27.5 Cr/quarter average; Q1's ₹18.57 Cr annualises to ~₹74 Cr — watch whether OPM (18.15% this quarter) keeps expanding to close the gap

  • W2

    Deployment of the remaining ~₹10.17 Cr IPO proceeds toward the Mambattu (Andhra Pradesh) refrigerant facility and its completion timeline

  • W3

    Revenue trajectory vs management's guided 30-35% three-year CAGR — Q1's 9.9% YoY growth trails that pace; watch for acceleration as backward integration and new facilities ramp

Only a standalone statement is filed (company states single business segment, no subsidiaries referenced); other income rose to ₹3.23 Cr (vs ₹0.74 Cr YoY) largely from interest on unutilised IPO proceeds parked in fixed deposits (note 5); Mar-31-2026 comparative column is a balancing figure per note 4; auditor issued an unmodified limited-review opinion.

Informational and educational content only. Not investment advice.

Stallion India Fluorochemicals Ltd (STALLION) Q1 FY27 Results — StockWatch